Help us identify barriers to accessing liver services in Scotland
We have partnered with the Scottish Hepatology Access Research Partnership (SHARP) to identify the barriers that are faced by people accessing liver services in Scotland, and how these barriers can be removed. In order to achieve this, we need your help. If you have a...
New Clinical Trial for primary sclerosing cholangitis
Asp-PSC is a ground-breaking clinical trial that aims to see if the risk of cancer for people with primary sclerosing cholangitis (PSC) can be reduced. PSC is a rare autoimmune liver disease affecting around 3,000 to 4,000 people in the UK. It is closely associated...
New study shows macrophage cell therapy holds promise to treat people with liver cirrhosis
A study led by the University of Edinburgh has looked at a new type of cell therapy for people with cirrhosis. They found that the treatment could reduce the risk of serious liver complications, and could in future help to prevent hospital admissions and deaths. At...
New Scottish research partnership aims to improve access to liver services
The British Liver Trust is providing patient representation and support for the Scottish Hepatology Access Research Partnership (SHARP). SHARP is a Scotland wide partnership that will bring together specialists in liver disease and public health, general...